Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China
· Delayed Price · Currency is CNY 10.57
+0.25 (2.42%)
At close: Mar 10, 2026
SHE:002873 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,487 | 2,190 | 2,868 | 3,339 | 3,224 | 1,869 | Upgrade
|
| Market Cap Growth | 11.90% | -23.62% | -14.13% | 3.58% | 72.48% | -4.04% | Upgrade
|
| Enterprise Value | 2,920 | 2,805 | 3,335 | 3,673 | 3,456 | 2,018 | Upgrade
|
| Last Close Price | 10.57 | 9.37 | 12.22 | 14.11 | 13.96 | 7.97 | Upgrade
|
| PE Ratio | 331.43 | 41.86 | 35.46 | 29.94 | 32.04 | 25.22 | Upgrade
|
| PS Ratio | 3.29 | 2.55 | 3.01 | 3.07 | 3.32 | 2.49 | Upgrade
|
| PB Ratio | 1.97 | 1.83 | 2.58 | 2.98 | 3.62 | 2.26 | Upgrade
|
| P/TBV Ratio | 2.15 | 2.02 | 2.79 | 3.22 | 4.01 | 2.50 | Upgrade
|
| P/FCF Ratio | 23.03 | 82.10 | - | - | 173.24 | 17.37 | Upgrade
|
| P/OCF Ratio | 16.64 | 24.85 | 36.87 | 44.04 | 25.94 | 10.63 | Upgrade
|
| EV/Sales Ratio | 3.87 | 3.27 | 3.50 | 3.38 | 3.56 | 2.69 | Upgrade
|
| EV/EBITDA Ratio | 48.62 | 31.46 | 28.38 | 23.64 | 23.30 | 19.13 | Upgrade
|
| EV/EBIT Ratio | 183.60 | 48.26 | 34.32 | 28.09 | 27.30 | 23.36 | Upgrade
|
| EV/FCF Ratio | 27.03 | 105.13 | - | - | 185.73 | 18.75 | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.47 | 0.54 | 0.43 | 0.48 | 0.68 | Upgrade
|
| Debt / EBITDA Ratio | 10.02 | 5.94 | 5.00 | 3.11 | 2.88 | 5.35 | Upgrade
|
| Debt / FCF Ratio | 5.57 | 21.00 | - | - | 23.10 | 5.25 | Upgrade
|
| Net Debt / Equity Ratio | 0.34 | 0.37 | 0.42 | 0.34 | 0.31 | 0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.87 | 4.96 | 3.95 | 2.48 | 1.87 | 1.10 | Upgrade
|
| Net Debt / FCF Ratio | 4.00 | 16.57 | -19.39 | -7.22 | 14.90 | 1.08 | Upgrade
|
| Asset Turnover | 0.37 | 0.44 | 0.51 | 0.65 | 0.63 | 0.57 | Upgrade
|
| Inventory Turnover | 1.31 | 1.40 | 1.19 | 1.64 | 1.96 | 1.83 | Upgrade
|
| Quick Ratio | 1.52 | 0.97 | 0.79 | 0.81 | 1.03 | 1.39 | Upgrade
|
| Current Ratio | 2.17 | 1.28 | 1.15 | 1.22 | 1.33 | 1.58 | Upgrade
|
| Return on Equity (ROE) | 0.65% | 4.53% | 7.24% | 11.08% | 11.71% | 9.64% | Upgrade
|
| Return on Assets (ROA) | 0.49% | 1.88% | 3.24% | 4.86% | 5.17% | 4.12% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.79% | 3.11% | 5.51% | 8.98% | 10.34% | 8.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.90% | 4.00% | 7.20% | 9.80% | 11.70% | 8.50% | Upgrade
|
| Earnings Yield | 0.30% | 2.39% | 2.82% | 3.34% | 3.12% | 3.96% | Upgrade
|
| FCF Yield | 4.34% | 1.22% | -0.83% | -1.60% | 0.58% | 5.76% | Upgrade
|
| Dividend Yield | 1.16% | 1.07% | 0.57% | 0.71% | 0.61% | 0.77% | Upgrade
|
| Payout Ratio | 549.88% | 67.01% | 52.59% | 30.81% | 30.15% | 35.39% | Upgrade
|
| Buyback Yield / Dilution | 0.98% | 9.91% | -0.41% | 0.41% | -1.34% | -6.59% | Upgrade
|
| Total Shareholder Return | 2.14% | 10.98% | 0.16% | 1.12% | -0.73% | -5.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.